MARCHESINI, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 452
EU - Europa 428
AS - Asia 184
AF - Africa 3
OC - Oceania 1
Totale 1.068
Nazione #
US - Stati Uniti d'America 443
IT - Italia 164
CN - Cina 102
IE - Irlanda 97
SG - Singapore 73
SE - Svezia 55
DE - Germania 32
AT - Austria 26
FI - Finlandia 12
FR - Francia 9
CA - Canada 8
CZ - Repubblica Ceca 8
GB - Regno Unito 8
IN - India 4
BE - Belgio 3
IL - Israele 3
CI - Costa d'Avorio 2
ES - Italia 2
GR - Grecia 2
NL - Olanda 2
PT - Portogallo 2
TR - Turchia 2
AU - Australia 1
BG - Bulgaria 1
EG - Egitto 1
LT - Lituania 1
LU - Lussemburgo 1
PA - Panama 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
UA - Ucraina 1
Totale 1.068
Città #
Chandler 114
Dublin 97
Singapore 61
Parma 50
Boardman 46
Shanghai 38
Ashburn 37
Santa Clara 27
Vienna 24
Ann Arbor 21
Milan 15
Beijing 14
Bremen 14
Princeton 14
Bologna 12
Wilmington 11
New York 10
Munich 9
Carpi 8
Dearborn 8
Brno 7
Nanjing 6
Ottawa 6
Dallas 5
Des Moines 5
Helsinki 5
Kunming 5
Modena 5
Fairfield 4
Frankfurt am Main 4
Hebei 4
Reggio Emilia 4
San Mateo 4
Changsha 3
Chicago 3
Hefei 3
Los Angeles 3
Nanchang 3
Perugia 3
Rome 3
Rovereto 3
Shenyang 3
Woodbridge 3
Abidjan 2
Amsterdam 2
Athens 2
Brussels 2
Chengdu 2
Cordovado 2
Cosenza 2
Falls Church 2
Fidenza 2
Houston 2
Izmir 2
Jiaxing 2
Jinan 2
Leytonstone 2
Marseille 2
Orzinuovi 2
Pescara 2
Pune 2
Rho 2
Sassuolo 2
Seattle 2
Tianjin 2
Toronto 2
Turin 2
Zhengzhou 2
Boretto 1
Bratislava 1
Cairo 1
Casoria 1
Catania 1
Cornaredo 1
Eboli 1
Esslingen am Neckar 1
Falkenstein 1
Fremont 1
Geislingen an der Steige 1
Genova 1
Ghent 1
Kolkata 1
Luxembourg 1
Male Hostice 1
Mezzolombardo 1
Naples 1
Norwalk 1
Redmond 1
Rockville 1
Segrate 1
Sofia 1
Tel Aviv 1
Verona 1
Vignola 1
Viterbo 1
Totale 801
Nome #
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia 118
Targeting oncogenic Notch signaling with SERCA inhibitors 112
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 83
ILF2-YB1 Protein Interaction Modulates RNA Splicing to Induce Resistance to Chemotherapy in High Risk Multiple Myeloma 76
ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma 69
Telomere Dysfunction Drives Aberrant Hematopoietic Differentiation and Myelodysplastic Syndrome 66
Strategies to Overcome Resistance Mechanisms in T-Cell Acute Lymphoblastic Leukemia 60
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML 55
ILF2-YB1 INTERACTION MODULATES RNA SPLICING TO INDUCE RESISTANCE TO DNA-DAMAGING AGENTS IN 1Q21-AMPLIFIED MULTIPLE MYELOMA 54
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function 51
PAF promotes stemness and radioresistance of glioma stem cells 49
Identification of the Atypical Protein Kinase WNK1 As a New Target in T-Cell Acute Lymphoblastic Leukemia 45
PML is required for telomere stability in non-neoplastic human cells 44
Genetic events that limit the efficacy of MEK and RTK inhibitor therapies in a mouse model of KRAS-driven pancreatic cancer 42
RNA processing: A new player of genomic instability in multiple myeloma 42
Down-regulation of EZH2 expression in myelodysplastic syndromes 36
A pool of peptides extracted from wheat bud chromatin inhibits tumor cell growth by causing defective DNA synthesis 35
SELECTIVE BLOCKADE OF ONCOGENIC NOTCH1 WITH THE NEW SERCA INHIBITOR CAD204520 19
Targeting DNA2 overcomes metabolic reprogramming in multiple myeloma 17
Selective Blockade of Oncogenic NOTCH1 with the New SERCA Inhibitor CAD204520 in T-cell Acute Lymphoblastic Leukemia 15
Targeting the Activating Mutations of NOTCH1 in T-Cell Lymphoblastic Leukemia with a New SERCA Inhibitor CAD204520 14
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 9
Totale 1.111
Categoria #
all - tutte 5.128
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.128


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202030 0 0 0 0 3 5 6 2 0 5 4 5
2020/202182 0 1 2 21 4 4 1 7 12 17 3 10
2021/202271 3 3 5 4 2 2 12 5 1 6 1 27
2022/2023404 22 43 19 38 50 44 14 25 118 4 23 4
2023/2024271 13 6 7 14 13 32 74 10 13 24 16 49
2024/2025184 12 29 27 64 52 0 0 0 0 0 0 0
Totale 1.111